Purchase Order 75N95025P00326
- Not listed
- The National Institute on Drug Abuse (NIDA) awarded a $15.7K purchase order to Biomed Services, Inc. for the procurement and installation of two vital sign monitors to support ongoing clinical operations and ensure participant safety across active clinical protocols. The contract, which carries a firm fixed-price structure with no set-aside designation, was awarded on July 23, 2025, with an ultimate completion date of September 23, 2025. Work will be performed at NIDA's facilities in...
- The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $83,907.10 firm-fixed-price purchase order to Biotage, LLC for the supply of a Biotage V-10 Touch System (Evaporator). This equipment will support NIDA's Automated Synthesis Platform for Innovative Research and Execution (ASPIRE) initiative, enabling rapid drying of organic and aqueous samples generated through chemistry workflows. The purchase order was awarded on...
- The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed-price purchase order contract to Med Associates, Inc., a for-profit, woman-owned manufacturer of behavioral research equipment. The $80,309.73 contract is for the delivery of specialized laboratory apparatus, operant conditioning systems, data analysis software, and other scientific instruments to support animal research on substance use disorders and...
- This is a $25,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Kiipo CO., a self-certified small disadvantaged business. The contract is for custom digital biomarker exploration to support NIDA's Immediate Response Program (IRP) data processing and other ecological momentary assessment (EMA) and just-in-time adaptive intervention (JITAI) research activities. The contract does not have a set-aside designation and has...
- The National Institute on Drug Abuse (NIDA) awarded a $11,595 firm-fixed-price purchase order to Tucker-Davis Technologies, Inc., effective June 30, 2025, with completion targeted for July 29, 2025. The contract encompasses fiber photometry accessories required to support bulk imaging of neuropeptides and neurotransmitters in the brain for ongoing research experiments conducted at NIDA's laboratory in Baltimore, Maryland. This procurement was issued without a set-aside designation....
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health, to Med Associates, Inc., a for-profit, woman-owned small business manufacturer and supplier of specialized scientific laboratory equipment and software. The contract award, valued at $18,898.50, is for the delivery of products that support research into substance use disorders, neurological processes, addiction mechanisms, and behavioral...
- The National Institute on Drug Abuse (NIDA), under the Department of Health and Human Services, awarded a $619,220 firm fixed-price purchase order to Instem LSS (North America) Limited for software licensing and support services. The contract, effective from September 29, 2025 through September 28, 2026, covers implementation and maintenance of Instem software modules including SEND Submit and Provantis at the National Center for Advancing Translational Sciences (NCATS). This non-competitive...
- The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $23,420.00 firm fixed price purchase order contract to Scireq Scientific Respiratory Equipment Inc. (doing business as Scireq), a for-profit vendor located in Baltimore, Maryland. The contract is for the provision of various scientific respiratory equipment and related items, including an IOX Complete Respiratory Analyzer, USBAMP 4 Channel Amplifier, and Dell Desktop, to support NIDA's biomedical research programs....
- The National Institute on Drug Abuse (NIDA), on behalf of the National Institute on Aging (NIA), awarded a $30,000.00 firm-fixed-price purchase order to Alamar Biosciences, Inc. to provide three 120 CNS kits to be used on the Alamar NULISA platform. These kits contain over 120 disease markers and will support research by the NIA's Laboratory of Clinical Investigation into biomarkers of neurodegenerative diseases found in exosomes isolated from patients' plasma. The award is a sole-source...
The National Institute on Drug Abuse (NIDA) awarded a $25,000 firm fixed-price purchase order to Biopac Systems, Inc. on July 22, 2025, with completion targeted for September 22, 2025. This contract supports NIDA's Intramural Research Program (IRP) acquisition of a physiological measurement system necessary for the bio-sensing and bio-prediction component of ecological momentary assessment (EMA) and just-in-time adaptive intervention (JITAI) studies. The award was not set aside for small businesses and will be performed at the vendor's operations or NIDA's facility in Baltimore, Maryland. Biopac Systems, Inc., a specialized biomedical research equipment manufacturer based in Goleta, California, was selected to provide the required physiological monitoring and data acquisition system. The company has an established track record supplying advanced scientific instrumentation to federal research agencies, including multiple National Institutes of Health divisions, with previous contracts primarily involving firm fixed-price purchase orders for physiological monitoring devices, sensors, and research-specific data acquisition systems. The equipment procured under this order will support ongoing clinical assessment activities integral to NIDA's substance use research and behavioral monitoring initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 7/23/25 |